22:07 IST
BSE
Business Update
Dr. Reddy's Laboratories Business Update
Dr. Reddy's Laboratories received two observations from the USFDA following a records assessment of its API manufacturing facility in Jiutepec, Mexico.
Dr. Reddy's Laboratories Ltd
Dr. Reddy's Laboratories Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,203.80
- Market cap
- ₹1,00,478 Cr
- Revenue (annual)
- ₹33,700 Cr
- Net profit (annual)
- ₹4,196 Cr
- P/E (TTM)
- 31.2×Sector 47.4×
- Promoter holding
- 26.64%+0.01% QoQ
- FII holding
- 20.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Price Movement Clarification 6Employee Stock Options 6Other Announcement 4Financial Results 4Business Update 4Earnings Call 3Board Meeting Outcome 3Product Launch 2Management Change 2Annual Report 2Annual General Meeting 2Regulatory Approval 1Partnership 1Merger & Restructuring 1Legal & Regulatory 1Capital Structure Change 1Board Meeting Date 1Adverse Business Impact 1
Time
4 announcements with these filters
22:59 IST
NSE
Business Update
Dr. Reddy's Laboratories Business Update
Dr. Reddy's Laboratories has terminated its distribution and promotion agreement with Novartis India Limited following a change in NIL's controlling shareholding.
21:38 IST
BSE
Business Update
Dr. Reddy's Laboratories Business Update
Dr. Reddy's Laboratories received a Form 483 with three observations following a USFDA inspection at its Srikakulam FTO-SEZ unit, which the company will address.
22:32 IST
BSE
Business Update
Dr. Reddy's Laboratories Business Update
USFDA completed a pre-license inspection at Dr Reddy's Bachupally facility. The company received a Form 483 with seven observations.